Condition: Chronic Subdural Hematoma · Atrial Fibrillation (AF) · Sponsor: Rahul Raj
The goal of this randomized clinical trial is to assess the benefit of early resumption versus late resumption of oral anticoagulation medication in adults with atrial fibrillation undergoing surgery for chronic subdural hematoma. The main questions it aims to answer are: * Does anticoagulation resumption 5 days after surgery as compared to 30 days after surgery result in fewer thromboembolic complications, without increasing the risk for bleeding? * Does anticoagulation resumption 5 days after surgery as compared to 30 days after surgery affect the risk of reoperation, functional outcome, mortality, and healthcare use? Researchers will compare early anticoagulation resumption (5 days) and late anticoagulation resumption (30 days) after chronic subdural hematoma surgery. Participants will either resume the medication 5 days or 30 days after the surgery. The participants will be followed up for 3 months after the surgery.
This description comes directly from the study's public registry record.
Rahul Raj, MD, PhD · +358504272516 · rahul.raj@hus.fi
Jarno Satopää, MD, PhD · +358504286743 · jarno.satopaa@hus.fi
Always discuss trial participation with your own doctor first.
| Oulu University Hospital | Oulu, North Ostrobothnia, Finland | Not Yet Recruiting |
| Kuopio University Hospital | Kuopio, Northern Savonia, Finland | Not Yet Recruiting |
| Tampere University Hospital | Tampere, Pirkanmaa, Finland | Not Yet Recruiting |
| Turku University Hospital | Turku, Southwest Finland, Finland | Not Yet Recruiting |
| Helsinki University Hospital | Helsinki, Uusimaa, Finland | Recruiting |
| Karolinska University Hospital | Stockholm, Region Stockholm, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06696079